Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats

Journal of Endocrinology

Volumn 198, Issue 2, 2008, Pages 395-401

  Böttner, Martina ^a   Christoffel, Julie ^b   Wuttke, Wolfgang ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 PRENYLNARINGENIN; ESTRADIOL BENZOATE; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SOMATOMEDIN C RECEPTOR; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HORMONAL REGULATION; HORMONE SUBSTITUTION; LIPID METABOLISM; LONG TERM CARE; LOW DRUG DOSE; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; UTERUS WEIGHT;

ADMINISTRATION, ORAL; ANIMALS; BODY WEIGHT; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTRADIOL; ESTROGENS; FEMALE; FLAVANONES; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LIPID METABOLISM; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; ORGAN SIZE; OVARIECTOMY; PHYTOESTROGENS; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES; UTERUS;

EID: 51349088136     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-08-0127     Document Type: Article

References (39)

1. Applebaum-Bowden D, McLean P, Steinmetz A, Fontana D, Matthys C, Warnick GR, Cheung M, Albers JJ & Hazzard WR 1989 Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. Journal of Lipid Research 30 1895-1906.
2. Berelowitz M, Szabo M, Frohman LA, Firestone S, Chu L & Hintz RL 1981 Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science 212 1279-1281.
3. Bottner M & Wuttke W 2006 Chronic treatment with physiological doses of estradiol affects the GH-IGF-1 axis and fat metabolism in young and middle-aged ovariectomized rats. Biogerontology 7 91-100.
4. Bottner M, Christoffel J, Rimoldi G & Wuttke W 2006a Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on the pituitar-thyroid-axis. Experimental and Clinical Endocrinology and Diabetes 114 82-90.
5. Bottner M, Christoffel J, Jarry H & Wuttke W 2006b Effects of long-term treatment with resveratrol and subcutaneous and oral estradiol administration on pituitary function in rats. Journal of Endocrinology 189 77-88.
6. Bovee TF, Helsdingen RJ, Rietjens IM, Keijer J & Hoogenboom RL 2004 Rapid yeast estrogen bioassays stably expressing human estrogen receptors α and β, and green fluorescent protein: a comparison of different compounds with both receptor types. Journal of Steroid Biochemistry and Molecular Biology 91 99-109.
7. Christoffel J, Rimoldi G & Wuttke W 2006 Effects of 8-prenylnaringenin on the hypothalamo-pituitary-uterine axis in rats after 3-month treatment. Journal of Endocrinology 188 397-405.
8. Coldham NG & Sauer MJ 2001 Identification, quantitation and biological activity of phytoestrogens in a dietary supplement for breast enhancement. Food and Chemical Toxicology 39 1211-1224.
9. Diel P Thomae RB, Caldarelli A, Zierau O, Kolba S, Schmidt S, Schwab P, Metz P & Vollmer G 2004 Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats. Planta Medica 70 39-44.
10. Duursma SA, Bijlsma JW, Van Paassen HC, van Buul-Offers SC & Skottner-Lundin A 1984 Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women; a pilot study. Acta Endocrinologica 106 527-531.
11. Fair T, Malkova J & Zivny J 2002 Effect of hormone replacement therapy on the cardiovascular system. Cesk Gynekologie 67 295-293.
12. Friday KE, Dong C & Fontenot RU 2001 Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 86 48-52.
13. Godsland IF 2004 Biology: risk factor modification by OCs and HRT lipids and lipoproteins. Maturitas 47 299-303.
14. Heyerick A, Vervarcke S, Depypere H, Bracke M & De Keukeleire D 2006 A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54 164-175.
15. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B & Vittinghoff E 1998 Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Journal of the American Medical Association 280 605-613.
16. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H & Wakabayashi I 2001 Estrogen receptor (ER)α, but not ERβ, gene is expressed in growth hormone-releasing hormone neurons of the male rat hypothalamus. Endocrinology 142 538-543.
17. Keefer DA, Stumpf WE & Petrusz P 1976 Quantitative autoradiographic assessment of 3H-estradiol uptake in immonocytochemically characterized pituitary cells. Cell Tissue Research 166 25-35.
18. Klammer H, Schlecht C, Wuttke W & Jarry H 2005 Multi-organic risk assessment of estrogenic properties of octyl-methoxycinnamate in vivo A 5-day sub-acute pharmacodynamic study with ovariectomized rats. Toxicology 215 90-96.
19. Knopp RH 2002 Risk factors for coronary artery disease in women. American Journal of Cardiology 89 28E-34E discussion 34E-35E.
20. Kushwaha RS, Foster DM, Murthy VN, Carey KD & Bernard MG 1990 Metabolic regulation of apoproteins of high-density lipoproteins by estrogen and progesterone in the baboon (Papio sp). Metabolism 39 544-552.
21. Leung KC, Johannsson G, Leong GM & Ho KK 2004 Estrogen regulation of growth hormone action. Endocrine Reviews 25 693-721.
22. Mallis LM, Sarkahian AB, Harris HA, Zhang MY & McConnell QJ 2003 Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry. Journal of Chromatography. B. Analytical Technologies in the Biomedical and Life Sciences 796 71-86.
23. Milligan SR, Kalita JC, Heyerick A, Rong H, De Cooman L & De Keukeleire D 1999 Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. Journal of Clinical Endocrinology and Metabolism 84 2249-2252.
24. Milligan SR, Kahta JC, Pocock V, Van De Kauter V, Stevens JF, Deinzer ML, Rong H & De Keukeleire D 2000 The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. Journal of Clinical Endocrinology and Metabolism 85 4912-4915.
25. Miyamoto M, Matsushita Y, Kiyokawa A, Fukuda C, Iijima Y, Sugano M & Akiyama T 1998 Prenylflavonoids: a new class of non-steroidal phytoestrogen (Part 2). Estrogenic effects of 8-isopentenylnaringenin on bone metabolism. Planta Medica 64 516-519.
26. Moorthy K, Yadav UC, Mantha AK, Cowsik SM, Sharma D, Basir SF & Baquer NZ 2004 Estradiol and progesterone treatments change the lipid profile in naturally menopausal rats from different age groups. Biogerontology 5 411-419.
27. Ohlsson C, Hellberg N, Parini P, Vidal O, Bohlooly YM, Rudling M, Lindberg MK, Warner M, Angelin B & Gustafsson JA 2000 Obesity and disturbed lipoprotein profile in estrogen receptor-α-deficient male mice. Biochemical and Biophysical Research Communications 278 640-645.
28. Rachon D, Vortherms T, Seidlova-Wuttke D & Wuttke W 2007 Dietary daidzein and puerarin do not affect pituitary LH expression but exert uterotropic effects in ovariectomized rats. Maturitas 57 161-170.
29. Rad M, Humpel M, Schaefer O, Schoemaker RC, Schleuning WD, Cohen AF & Burggraaf J 2006 Pharmacokinetics and systemic endocrine effects of the phyto-oestrogen 8-prenylnaringenin after single oral doses to postmenopausal women. British Journal of Clinical Pharmacology 62 288-296.
30. Rimoldi G, Christoffel J & Wuttke W 2006 Morphologic changes induced by oral long-term treatment with 8-prenylnaringenin in the uterus, vagina, and mammary gland of castrated rats. Menopause 13 669-677.
31. Rimoldi G, Christoffel J, Seidlova-Wuttke D, Jarry H & Wuttke W 2007 Effects of chronic genistein treatment in mammary gland, uterus, and vagina. Environmental Health Perspectives 115 (Suppl 1) 62-68.
32. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. 2002 Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288 321-333.
33. Saglam K, Polat Z, Yilmaz MI, Gulec M & Akinci SB 2002 Effects of postmenopausal hormone replacement therapy on insulin resistance. Endocrine 18 211-214.
34. Schaefer O, Humpel M, Fritzemeier KH, Bohlmann R & Schleuning WD 2003 8-Prenyl naringenin is a potent ER α selective phytoestrogen present in hops and been. Journal of Steroid Biochemistry and Molecular Biology 84 359-360.
35. Seidlova-Wuttke D, Hesse O, Jarry H, Christoffel V, Spengler B, Becker T & Wuttke W 2003 Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-l7beta. European Journal of Endocrinology 149 351-362.
36. Staels B, Jansen H, van Tol A, Stahnke G, Will H, Verhoeven G & Auwerx J 1990 Development, food intake, and ethinylestradiol influence hepatic triglyceride lipase and LDL-receptor mRNA levels in rats. Journal of Lipid Research 31 1211-1218.
37. Stefaneanu L, Kovacs K, Horvath E, Lloyd RV, Buchfelder M, Fahlbusch R & Smyth H 1994 In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 78 83-88.
38. Wiedemann E, Schwartz E & Frantz AG 1976 Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man. Journal of Clinical Endocrinology and Metabolism 42 942-952.
39. Zierau Q, Hamann J, Tischer S, Schwab P, Metz P, Vollmer G, Gutzeit HO & Scholz S 2005 Naringenin-type flavonoids show different estrogenic effects in mammalian and teleost test systems. Biochemical and Biophysical Research Communications 326 909-916.